General Information of Drug (ID: DMULZ4W)

Drug Name
CHR-2797 Drug Info
Synonyms Tosedostat; Tosedostat, CHR2797, CHR-2797
Indication
Disease Entry ICD 11 Status REF
Acute myeloid leukaemia 2A60 Phase 2 [1]
Myelodysplastic syndrome 2A37 Phase 2 [2]
Inflammation 1A00-CA43.1 Terminated [3]
Therapeutic Class
Anticancer Agents
Cross-matching ID
PubChem CID
15547703
ChEBI ID
CHEBI:95044
CAS Number
CAS 238750-77-1
TTD Drug ID
DMULZ4W

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ANTAQ DMA7LUR Discovery agent N.A. Investigative [5]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Aminopeptidase (AMP) TTWLEZV NOUNIPROTAC Inhibitor [2]
Puromycin-sensitive aminopeptidase (NPEPPS) TT371QC PSA_HUMAN Inhibitor [4]

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022187)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800014340)
4 CHR-2797: an antiproliferative aminopeptidase inhibitor that leads to amino acid deprivation in human leukemic cells. Cancer Res. 2008 Aug 15;68(16):6669-79.
5 Fluorescent bioprobes for visualization of puromycin-sensitive aminopeptidase in living cells. Bioorg Med Chem Lett. 2003 Jan 6;13(1):83-6.